federal_register: 2026-09292
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| document_number | title | type | abstract | publication_date | pub_year | pub_month | html_url | pdf_url | agency_names | agency_ids | excerpts | regulation_id_numbers |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-09292 | Government Owned Inventions Available for License: Enhanced Tumor Reactivity of T Cells Lacking SIT1, LAX1 or TRAT1 | Notice | The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) is actively seeking potential licensees interested in further developing these inhibitory transmembrane adapter proteins as targets for T-cell immunotherapy for the treatment of cancer, infectious diseases, and autoimmune diseases. | 2026-05-11 | 2026 | 5 | https://www.federalregister.gov/documents/2026/05/11/2026-09292/government-owned-inventions-available-for-license-enhanced-tumor-reactivity-of-t-cells-lacking-sit1 | https://www.govinfo.gov/content/pkg/FR-2026-05-11/pdf/2026-09292.pdf | Health and Human Services Department; National Institutes of Health | 221,353 | The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) is actively seeking potential licensees interested in further developing these inhibitory transmembrane adapter proteins as targets for T-cell immunotherapy for... |